Skip to main content

Strahlentherapie und Onkologie

Ausgabe 3/2013

Inhalt (17 Artikel)

Editorial

Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy?

F. Sedlmayer, M.L. Sautter-Bihl, W. Budach, J. Dunst, P. Feyer, R. Fietkau, W. Haase, W. Harms, C. Rödel, R. Souchon, F. Wenz, R. Sauer

Original article

Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy

A. Abramyuk, S. Appold, K. Zöphel, M. Baumann, N. Abolmaali

Original article

Cyclin D1, EGFR, and Akt/mTOR pathway

D. Dionysopoulos, K. Pavlakis, V. Kotoula, E. Fountzilas, K. Markou, I. Karasmanis, N. Angouridakis, A. Nikolaou, K.T. Kalogeras, G. Fountzilas

Original article

Xerostomia after radiotherapy

S. Tribius, J. Sommer, C. Prosch, A. Bajrovic, A. Muenscher, M. Blessmann, A. Kruell, C. Petersen, M. Todorovic, P. Tennstedt

Original article

Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy

M. Lambrecht, D. Nevens, S. Nuyts

Original article

Dysphagia after definitive radiotherapy for head and neck cancer

L. Deantonio, L. Masini, M. Brambilla, F. Pia, M. Krengli

Original article

Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients

M.P. Schmid, B. Mansmann, M. Federico, J.C.A. Dimopoulous, P. Georg, E. Fidarova, W. Dörr, R. Pötter

Original article

In vitro hypoxic cytotoxicity and hypoxic radiosensitization

M. Langenbacher, R.J. Abdel-Jalil, W. Voelter, M. Weinmann, S.M. Huber

Case study

Intraoperative radiotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Y.L.B. Klaver, V.E.P.P. Lemmens, S.W. Nienhuijs, G.A.P. Nieuwenhuijzen, H.J.T. Rutten, I.H.J.T. de Hingh

Laudatio

Professor Manfred Strietzel zum 85. Geburtstag

Th. Herrmann, J. Schorcht

Nachruf

Zum Gedenken an Roch Kowalski

H.-P. Heilmann, M. Busch, H.-J. Brodersen

Literatur kommentiert

Primäre kurative Radiochemotherapie beim Nasopharynxkarzinom

H. Christiansen, H.A. Wolff

Mitteilungen der Fachgesellschaften

Mitteilungen der Fachgesellschaften

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.